Though the Food and Drug Administration is in the process of developing long overdue guidance on these issues, many in the sector don't expect a clear set of rules. In the meantime, people are talking about their drugs and products at a near-constant rate online; plus, pharmaceutical firms realize they need to develop new ways of communicating with physicians in digital environments.
